|
|
|||||||||
In Brief |
| The first 20% of the full text of this article appears below. |
Health Supervision for Children With Achondroplasia. American Academy of Pediatrics: Clinical Report.
Pediatrics. 2005;116
:771
–783
Achondroplasia. Horton WA, Hall JG, Hecht JT. Lancet. 2007;370 :162 –172[CrossRef][Medline]
Mortality in Achondroplasia Study: A 42-Year Follow-Up. Wynn J, King TM, Gambello MJ, et al. Am J Med Genet. 2007;143A :2502 –2511
Weight for Age Charts for Children with Achondroplasia. Hoover-Fong JE, McGready J, Schulze KJ, et al. Am J Med Genet. 2007;143A :2227 –2235
Achondroplasia is the most common of the skeletal dysplasias and the most common condition associated with disproportionate short stature. The incidence is 1 in 10,000 to 1 in 30,000 live births, with more than 250,000 people affected worldwide. The disorder is transmitted as an autosomal dominant trait with complete penetrance. However, in more than 75% of affected infants, achondroplasia results from a new mutation. The genetic defect in more than 95% of cases is an arginine-for-glycine substitution in amino acid 380 in the gene, mapped to band 4p16.3, that codes
William B. Stratbucker, MD, MS
Helen DeVos Children's Hospital
Michigan State University
Grand Rapids, Mich
Janet R. Serwint, MD, Consulting Editor
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |